Myeloid cell leukemia sequence 1 (Mcl-1), an antiapoptotic member of the Bcl-2 family, is often overexpressed in tumor cells limiting the therapeutic success. Mcl-1 differs from other Bcl-2 members by its high turnover rate. Its expression level is tightly regulated by ubiquitylating and deubiquitylating enzymes. Interaction of Mcl-1 with certain Bcl-2 homology domain 3 (BH3)-only members of the Bcl-2 family can limit the access to Mcl-1 ubiquitin ligase E3 and stabilizes the antiapoptotic protein. In addition, the overexpression of the deubiquitinase ubiquitin-specific protease 9x (USP9x) 
Introduction
The success of many antineoplastic therapies is based on a thorough removal of tumor cells through induction of apoptosis. Ionizing radiation that is commonly used in anticancer therapies and many cytotoxic drugs, e.g., anthracyclines, induces cell death through the mitochondrial pathway that is controlled by the Bcl-2 protein family. The family is subdivided into an antiapoptotic group consisting of Bcl-2 itself, Bcl-xL, and myeloid cell leukemia sequence 1 (Mcl-1) among others and a proapoptotic group. The latter comprises the multidomain proteins Bax, Bak, and Bok, as well as several Bcl-2 homology domain 3 (BH3)-only containing proteins [1] . The antiapoptotic members maintain mitochondrial integrity, prevent the release of proapoptotic factors from the intermembrane space into the cytosol and the subsequent caspase activation. In addition, the protective Bcl-2, Bcl-xL, and Mcl-1 are overexpressed in diverse tumors and constitute resistance factors that prevent a successful antitumor therapy [2, 3] . Therefore, understanding the regulatory mechanisms of the antiapoptotic proteins is crucial for the success of future therapies.
The antiapoptotic proteins can interact with the BH3 domain of proapoptotic Bcl-2 members to neutralize each other [4] . Although all antiapoptotic Bcl-2 family members exhibit redundant protective function, they cannot always substitute each other [5] [6] [7] . Moreover, the protective proteins are regulated by distinct mechanisms at the transcriptional, translational, and posttranslational levels [8] [9] [10] . In contrast to Bcl-2 and Bcl-xL, Mcl-1 is a short-lived protein with a high turnover rate. Shutdown of protein translation results in a rapid decline [10] . Sequestration by BH3-only proteins and phosphorylation reportedly regulate Mcl-1 degradation [11] [12] [13] [14] [15] . Interestingly, different kinases can have opposite effect on the turnover of Mcl-1. Whereas phosphorylation by extracellular regulated kinases 1 and 2 (ERK1/2) at threonine 163 slows Mcl-1 protein turnover, phosphorylation at serine 159 by glycogen synthase kinase-3β (GSK-3β) targets Mcl-1 for ubiquitylation and proteasomal degradation [12, 14] . The transfer of ubiquitin moieties is catalyzed by ubiquitin ligases. So far, three ubiquitin ligases targeting Mcl-1 were identified, namely, Mcl-1 ubiquitin ligase E3 (Mule), β-transducin repeat-containing protein (β-TrCP), and FBW7 [16] [17] [18] [19] . β-TrCP and FBW7 are the Mcl-1-recognizing components of the Skip/Collin/F-box ubiquitin ligase complex. Previous publications indicate that phosphorylation of Mcl-1 accelerates β-TrCP-or FBW7-dependent degradation of the antiapoptotic protein [16, 18] . The single peptide ligase Mule, in contrast, contains a BH3-like domain through which the enzyme interacts with Mcl-1 similar to the complex formed by Mcl-1 with other BH3-only proteins [19] . Consequently, Noxa-and probably also Bim and Puma-can limit the access of Mule and Muledependent degradation of Mcl-1 while interacting with the antiapoptotic protein [13, 15] .
The ubiquitylation can be reversed by deubiquitinases. Recently, the deubiquitinase ubiquitin-specific protease 9x (USP9x) was described to remove poly-ubiquitin chains from Mcl-1, thereby stabilizing the protective protein and increasing resistance to apoptosis induced by the Bcl-2/Bcl-xL inhibitor ABT-737 [20] . Increased USP9x expression correlates with Mcl-1 protein levels in human follicular and diffuse large B-cell lymphomas and is associated with poor prognosis for patients with multiple myeloma [20] .
Despite the growing knowledge about the mechanisms controlling Mcl-1 stability, little is known how Mcl-1 levels are regulated in response to ionizing radiation (IR). Using Jurkat T lymphoma cells, we analyzed the sensitivity of two clones to IR-induced apoptosis. The sensitive cells died faster and exhibited a lower clonogenic survival upon irradiation than the resistant cells. In both clones, the radiosensitivity correlated with IR-induced Mcl-1 decline, and the reduction of Mcl-1 levels was prerequisite for apoptosis induction. Thus, the ability to maintain high Mcl-1 levels for a much longer time might explain the reduced radiosensitivity of the resistant cell clone. Interestingly, inhibition of GSK-3β could not prevent Mcl-1 degradation, suggesting that the kinase does not regulate Mcl-1 stability. To further analyze the mechanism controlling Mcl-1 turnover, BH3-only proteins Bim, Puma, and Noxa and the deubiquitinase USP9x were silenced by siRNA. However, knockdown of none of the BH3-only proteins affected the Mcl-1 level or IR-induced apoptosis.
IR induced activation of USP9x in resistant Jurkat cells 24 hours after irradiation. This activation coincided with an enhanced interaction between USP9x and Mcl-1 and enhanced Mcl-1 deubiquitylation. Accordingly, knockdown of USP9x accelerated the radiation-induced Mcl-1 degradation and sensitized the radioresistant Jurkat subclone and another tumor cell line, the radioresistant K562 chronic myelogenous leukemia cells, to apoptosis. We conclude that radioresistance can be acquired by activation of USP9x that stabilizes Mcl-1 protein levels and increases cell survival.
Materials and Methods

Reagents and Antibodies
Pan-caspase inhibitor zVAD-fmk was purchased from Bachem (Bubendorf, Switzerland), cycloheximide from Sigma (Deisenhofen, Germany), GSK-3 inhibitor XV and MG132 from Calbiochem (Merck, Darmstadt, Germany), and WP1130 from Selleck Chemicals (Munich, Germany).
The following antibodies were used for Western blot analysis and immunoprecipitation: mouse anti-caspase-9 and rabbit anti-Bak from Upstate (Millipore, Schwalbach, Germany), rabbit anti-caspase-3, poly (ADP ribose) polymerase (PARP), Mcl-1, Bcl-xL, β-catenin, GSK-3β, phospho-GSK-3β (S21/9), Akt, phospho-Akt (S473) and phosphoAkt (T308), and mouse anti-ubiquitin (clone P4D1) from Cell Signaling (NEB, Frankfurt, Germany), rabbit anti-Puma and Bim from Epitomics (Biomol, Hamburg, Germany), mouse anti-Bcl-2 from Santa Cruz Biotechnology (Heidelberg, Germany), mouse anti-Noxa from Calbiochem (Merck), rabbit anti-USP9x from Novus Biologicals and mouse anti-USP9x from Abnova (both distributed by Acris, Heford, Germany), mouse anti-Mcl-1 from Pharmingen (Becton Dickinson, Heidelberg, Germany), mouse anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) from Abcam (Cambridge, United Kingdom), and mouse anti-β-actin from Sigma.
Cells and Cell Culture
Jurkat E6 T lymphoma cells ( Jurkat-sensitive) and K562 chronic myelogenous leukemia cells were from ATCC (Bethesda, MD). The radioresistant Jurkat subclone emerged after a prolonged cell culture. Cells were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (Gibco Life Technologies, Eggenstein, Germany) and maintained in a humidified incubator at 37°C and 5% CO 2 .
Transfection with siRNA
Cells were cultured at a low density to ensure log phase growth. For transfection, 3 × 10 6 cells were resuspended in 300 μl of RPMI-1640 without phenol red. After adding siRNA at indicated concentrations, Jurkat cells were electroporated at 370 V for 10 ms and K562 cells at 340 V for 5 ms, using an EPI2500 electroporator (Fischer, Heidelberg, Germany). Immediately after transfection, cells were resuspended in prewarmed medium and continued to be cultured as described above. Transfection efficiency and viability were determined by transfecting the cells with 400-nM green fluorescence siGLO siRNA followed by propidium iodide exclusion dye and flow cytometric analysis. Mcl-1, Puma, Bim, Noxa, USP9x ON-TARGET SMARTpools, siCONTROL NON-TARGETING pool, and siGLO siRNA were purchased from Dharmacon (Chicago, IL).
Flow Cytometric Analysis
The mitochondrial membrane potential (ΔΨ m ) was analyzed using the ΔΨ m -specific dye tetramethylrhodamine ethyl ester (Molecular Probes, Mobitech, Goettingen, Germany). At the indicated time points, cells were stained for 30 minutes in phosphate-buffered saline (PBS) containing 25 nM tetramethylrhodamine ethyl ester. To examine DNA fragmentation, we incubated cells with PBS containing 0.1% Triton X-100 and 10 μg/ml propidium iodide. Short-term survival was measured employing a propidium iodide exclusion dye. The cells were incubated with PBS containing 10 μg/ml propidium iodide in the absence of any detergent. Cells were detected in channel 2 employing a FACS Calibur flow cytometer (Becton Dickinson) and analyzed with the FCS Express 3 software (De Novo Software, Los Angeles, CA). Data show mean values ± SD of at least six independent experiments.
Clonogenic Test
Clonogenic survival was analyzed as described before [21] . In brief, cells were seeded at different dilutions and irradiated with 0 to 8 Gy. For each dilution, the amount of wells that shows a repopulation 4 weeks after irradiation was counted. Using the Origin 6.0 software (Microcal Inc., Northampton, MA), the amount of cells that was needed to repopulate 50% of the wells (WC50) was calculated. The surviving fraction (SF) was calculated by normalizing the WC50 values of irradiated cells to the WC50 values of the respective nonirradiated control cells. The error of SF was calculated by error propagation according to Gauss.
Western Blot Analysis
Cells were lysed in 200 μl of lysis buffer containing 50 mM Hepes (pH 7.5), 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 10 mM sodium pyrophosphate, 10 mM NaF, 2 mM Na 3 VO 4 , 100 mM PMSF, 5 μg/ml aprotinin, 5 μg/ml leupeptin, and 3 μg/ml pepstatin. Protein was separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) under reducing conditions and transferred onto polyvinylidene fluoride (PVDF) membranes (Roth, Karlsruhe, Germany). Blots were blocked in TBS buffer containing 0.05% Tween 20 and 5% nonfat dry milk for 1 hour at room temperature. The membrane was incubated overnight at 4°C with the respective primary antibodies. The secondary antibody was incubated for 1 hour at room temperature. Detection of antibody binding was performed by enhanced chemiluminescence (ECL Western Blotting Analysis System; GE Healthcare/Amersham Biosciences, Freiburg, Germany). Equal loading was verified by antibodies against GAPDH or β-actin. Where indicated, protein levels were quantified by densitometry using the ImageJ software (ImageJ 1.40g, National Institutes of Health, Bethesda, MD). All Western blot experiments were repeated at least once.
Immunoprecipitation
Cells were lysed as described above using 1% CHAPS as detergent. The protein concentration was adjusted to 2 mg/ml. Two micrograms of anti-USP9x antibody (Novus Biologicals) or 10 μl of anti-Mcl-1 antibody (Cell Signaling) and 50 μl of slurry Dynabeads suspension (Dynal/Invitrogen, Karlsruhe, Germany) were added to 750 μl of lysate. After precipitation for 3 hours at 4°C, the beads were washed thrice with 300 μl of lysis buffer containing 0.2% of the respective detergent. Proteins were eluted by boiling the beads for 10 minutes in 100 μl of SDS sample buffer containing 2.5% β-mercaptoethanol. Thirty microliters of the eluate was separated by SDS-PAGE before transfer to PVDF membrane and detection by chemiluminescence as described above. Immunoprecipitations were repeated at least once.
Ubiquitin-7-amino-4-methylcoumarin (AMC) Assay
Cells were lysed in DUB buffer [20 mM Hepes (pH 7.5), 150 mM NaCl, 0.5% NP-40, and 5 mM MgCl 2 ]. Five hundred micrograms of protein was precipitated with 1 μg of rabbit anti-USP9x antibody as described above. Washed beads were suspended in 100 μl of DUB buffer. The reaction was started by adding 500 nM ubiquitin-AMC and detected with a Tecan microplate reader (Infinite 200, Tecan, Mainz, Germany) using excitation at 380 nm and emission at 460 nm.
Six independent experiments were performed. Data represent mean values ± SD.
USP9x-Mcl-1 Assay
IR-resistant cells were irradiated with 0 or 10 Gy or treated with 5 μM MG132. Twenty-four hours after irradiation, cells were lysed in buffer containing 20 mM Hepes (pH 7.5), 150 mM NaCl, 1% CHAPS, and 5 mM MgCl 2 . USP9x was precipitated as described above. Alternatively, cells treated with MG132 were lysed and Mcl-1 was precipitated from the lysates as described above. The precipitates were washed three times with a buffer containing 20 mM Hepes (pH 7.5), 150 mM NaCl, 0.2% CHAPS, and 5 mM MgCl 2 and resuspended in 20 μl of washing buffer additionally containing 50 μl of dithiothreitol (DTT). The precipitated Mcl-1 was added to the USP9x precipitates and incubated for 30 minutes at 37°C. Where indicated, USP9x activity was inhibited by adding 5 μM WP1130 before uniting with precipitated Mcl-1. Afterward, precipitates were separated by SDS-PAGE under reducing conditions and analyzed by Western blot using antibodies against ubiquitin, Mcl-1, and USP9x.
Mcl-1 Degradation Assay
Cells were treated with 1 μM cycloheximide for 0, 0.5, 1, 2, and 3 hours. At indicated time points, cells were lysed and lysates were separated as described above. Mcl-1 protein levels were detected by Western blot analysis. Several Western blots were made from the same lysates. Protein levels were quantified by densitometry using ImageJ software (ImageJ 1.40g, National Institutes of Health). Monoexponential decay was fitted using Origin 6.0 software and normalized as described in the legend.
Data Analysis
Statistical significance was calculated by a one-way analysis of variance (ANOVA) test using GraphPad Software (San Diego, CA).
Results
Effective Down-regulation of Mcl-1 Correlates with Radiosensitivity in Jurkat Lymphoma Cells
To analyze resistance mechanisms that prevent apoptosis induction in response to IR, we irradiated two clones of Jurkat T lymphoma cells with 10 Gy. Dissipation of the mitochondrial membrane potential (ΔΨ m ) and DNA degradation (sub-G1 population) were analyzed by flow cytometry (Figure 1 , A-D). The clones differ in their sensitivity to radiation-induced apoptosis. ΔΨ m dissipation and DNA degradation occurred more efficiently in the IR-sensitive parental clone than in the IR-resistant subclone ( Figure 1, A-D) .
Furthermore, short-term survival upon irradiation with 10 Gy was analyzed employing a propidium iodide exclusion dye ( Figure 1E ), whereas long-term survival was examined by clonogenic assay using limiting cell dilutions to calculate the SF ( Figure 1F ). Both assays showed that the short-term as well as the long-term survival was lower in the IR-sensitive cells. The activation of the initiator caspase-9, the executioner caspase-3, and cleavage of caspase-3 substrate PARP were impaired in the resistant cells after irradiation ( Figure 1G ). The levels of the antiapoptotic Bcl-2 and Bcl-xL, as well as of the proapoptotic Bcl-2 family members Bak and Bim, remained unchanged in both cell clones. However, levels of the antiapoptotic Mcl-1 visibly decreased in the IR-sensitive cells, whereas levels of the specific Mcl-1 interacting BH3-only protein Noxa were unaffected ( Figure 1G ).
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To clarify the importance of Mcl-1 down-regulation for mitochondrial permeabilization and apoptosis induction, we electroporated nontargeting (nt) or Mcl-1-targeting (mcl1) siRNA into both clones. Mcl-1 levels were reduced by the specific siRNA already 3 hours after electroporation and not detectable 3 more hours later (Figure 2A 
GSK-3β Does Not Control Mcl-1 Stability in Jurkat Cells
Because Mcl-1 is essential for Jurkat cell survival, we set out to analyze the mechanisms regulating its protein levels. Mcl-1 function and stability can be controlled by BH3-only proteins, by kinases like GSK-3β, by ubiquitin ligases facilitating proteasomal degradation, and by deubiquitinases preventing proteasomal degradation.
First, we analyzed the regulation of Mcl-1 by GSK-3β. The kinase GSK-3β is inactive when phosphorylated by PKB/Akt, thus unable to phosphorylate and destabilize Mcl-1. Interestingly, IR had no impact on phospho-Akt and phospho-GSK-3β in Jurkat cells, even though Mcl-1 and β-catenin levels decreased ( Figure 3A) . To test whether GSK-3β influences radiation-induced apoptosis, we treated IR-sensitive cells with 30 nM GSK-3 inhibitor XV when irradiated with 10 Gy. Treatment with GSK-3 inhibitor XV resulted in an accumulation of the GSK-3β target β-catenin without changing Mcl-1 levels or IRinduced Mcl-1 decline ( Figure 3B ). Flow cytometric analysis showed that ΔΨ m dissipation ( Figure 3C ) and DNA degradation ( Figure 3D ) occurred to the same extent in inhibitor-or vehicle-treated cells. 
BH3-only Proteins Are Not Involved in Mcl-1 Stability
Our next focus was on those BH3-only proteins, which are known interaction partners of Mcl-1. Bim, Puma, and Noxa were described to be upregulated in response to irradiation. In our cell system, however, Bim and Noxa levels remained unchanged ( Figure 1G ), whereas Puma levels decreased 24 hours after irradiation in IR-sensitive cells. Cotreatment of those cells with the pan-caspase inhibitor zVAD abrogated the decline of Puma but not of Mcl-1 ( Figure 4A ), indicating that change of Puma levels occurred in the executive phase of apoptosis after caspase activation, whereas Mcl-1 was downregulated before caspases became activated (Figures 1G and 4A) .
The association of the BH3-only proteins with Mcl-1 might change during radiation-induced apoptosis independent of their protein levels. We, therefore, silenced the expression of Bim, Puma, and Noxa by siRNA in the sensitive clone. Down-regulation of respective proteins was verified by Western blot analysis 72 hours after electroporation (Figure 4 , B-D, upper panels). Two days after electroporation, cells were irradiated with 10 Gy. ΔΨ m dissipation (Figure 4 , B-D, middle panels) and DNA degradation ( Figure 4 , B-D, lower panels) were analyzed 24 and 48 hours after irradiation, respectively. Surprisingly, silencing of Bim, Puma, or Noxa did not alter Mcl-1 protein levels, radiation-induced ΔΨ m dissipation, and DNA degradation. The results indicate that none of the three BH3-only proteins regulates radioresistance in the Jurkat cells.
USP9x Controls Mcl-1 Stability in Jurkat Lymphoma Cells
In previous publications, USP9x was shown to interact with Mcl-1 and β-catenin [20, 22] . Both proteins were downregulated only in An enhanced association of USP9x with Mcl-1 does not necessarily reflect an enhanced USP9x enzymatic activity. Thus, we performed a fluorometric activity assay following precipitation of USP9x from irradiated and nonirradiated control cells. Notably, a significant increase of USP9x activity could be detected only in IR-resistant but not in IR-sensitive cells 24 hours after irradiation ( Figure 6A ). Using a pan-phospho-serine/threonine antibody, we also detected an IR-induced phosphorylation of USP9x, which was markedly higher in the IR-resistant than in IR-sensitive cells indicating a posttranslational modification in response to IR ( Figure W1A) .
Moreover, when adding purified ubiquitylated Mcl-1 to precipitated USP9x, we could detect a decrease of ubiquitylated, high mo- control cells (Figure 6C) . Such a decrease of ubiquitylated, high molecular Mcl-1 was not observed in IR-sensitive cells 24 hours after irradiation. Interestingly, an overall change of ubiquitylated proteins, such as is observed 3 hours after treatment with 5 μM proteasome inhibitor MG132, could not be detected in Jurkat cells 24 hours after irradiation with 10 Gy (Figure 6D ), indicating a specific regulation of Mcl-1 ubiquitylation status following irradiation.
USP9x Knockdown Sensitizes Radioresistant Cells to IR-induced Apoptosis
The observation was also supported in the next set of experiments in which USP9x was downregulated by siRNA. USP9x knockdown was verified 48 hours after electroporation with 1 μM nontargeting or USP9x-targeting siRNA. Interestingly, depletion of USP9x did not affect Mcl-1 levels in IR-sensitive or IR-resistant cells ( Figure 7A ). Forty-eight hours after electroporation, IR-sensitive and IR-resistant cells were irradiated with 10 Gy. Twenty-four and forty-eight hours after irradiation, ΔΨ m ( Figure 7B ) and cellular DNA content ( Figure 7C (Figure 7, E-G) . Although irradiation alone reduced slightly, but not significantly, Mcl-1 half-life, USP9x knockdown resulted in a further significant reduction of Mcl-1 half-life. Our results indicate that USP9x stabilizes Mcl-1 upon irradiation in the resistant Jurkat subclone, whereas it has no effects on Mcl-1 in nonirradiated cells.
To exclude an effect limited to our Jurkat cell model, we examined the role of USP9x in radiation-induced apoptosis in another cell line. Irradiation with 10 Gy hardly induced caspase-3 activation and PARP cleavage within the first 48 hours in K562 cells, a chronic myelogenous leukemia cell line ( Figure 8A) . A decrease of Mcl-1 levels was observed not until 48 hours after irradiation. Therefore, hardly any DNA fragmentation was detected until 72 hours after irradiation ( Figure 8B ). Obviously, K562 cells are very refractory to radiationinduced apoptosis. Silencing of USP9x by siRNA significantly enhanced DNA degradation 72 hours after irradiation ( Figure 8C ) and also accelerated Mcl-1 decline as well as caspase-3 and PARP processing ( Figure 8D) . Thus, the radioprotective effects of USP9x were observed not only in radioresistant Jurkat cells but also in radioresistant K562 cells, indicating a more general mechanism of radioresistance mediated by USP9x.
Taken together, our findings suggest a novel mechanism of radioresistance that involves the activation of the deubiquitinase USP9x and the USP9x-dependent stabilization of Mcl-1 following irradiation.
Discussion
Failure to Downregulate Mcl-1 Mediates Radioresistance
Ionizing radiation is widely used in antitumor therapies because of its antiproliferative and cytotoxic effects. The response to irradiation varies profoundly between different tumors. Factors responsible for radioresistance need to be identified and targeted to improve the therapeutical outcome. The related proteins Bcl-2, Bcl-xL, and Mcl-1 are already identified as radioresistance factors [23] [24] [25] [26] [27] . When overexpressed, they prevent radiation-induced apoptosis, enhance survival, and impair tumor response to radiotherapy. In our present study, we focused on Mcl-1 whose stability is tightly regulated by ubiquitin ligases and deubiquitinases. For the first time, we could show that the deubiquitinase USP9x contributes to radioresistance by stabilizing Mcl-1 protein levels.
To identify a molecular mechanism regulating radioresistance, we used two Jurkat lymphoma cell clones that differ in their radiosensitivity, which arose spontaneously after prolonged cell culture. IR-induced apoptosis was delayed in resistant cells. In addition, short-term as well as long-term survival was significantly lower in sensitive cells upon radiation. Interestingly, the down-regulation of Mcl-1 protein levels in response to IR occurred faster in sensitive cells. The survival of both cell clones depended on Mcl-1 because down-regulation of Mcl-1 by siRNA resulted in a rapid mitochondrial permeabilization and thus in cell death. We, therefore, concluded that the failure of efficient Mcl-1 down-regulation was probably responsible for enhanced survival or the IR-resistant cells following irradiation. Those results support an earlier observation that IR-induced depletion of Mcl-1 correlated with radiation-induced apoptosis [28] . Other experiment, however, indicate that apoptosis can proceed without Mcl-1 degradation [29] . Thus, we cannot exclude the involvement of other factors controlling the radiosensitivity in Jurkat cells.
Many tumors exceedingly overexpress Mcl-1 and fail to downregulate the protective protein in response to single drug treatment, underlining the importance to reduce Mcl-1 half-life time to increase therapeutic success [30, 31] . We detected decreased Mcl-1 turnover in sensitive Jurkat cells 24 hours after irradiation, whereas Mcl-1 half-life time was not significantly changed in resistant cells. Several possible mechanisms controlling Mcl-1 stability were described so far including the binding to BH3-only proteins, phosphorylation by kinases, and the regulation of its ubiquitylation status by ubiquitin ligases and deubiquitinases.
Regulation of Mcl-1 Stability and Radioresistance by BH3-only Proteins and Ubiquitin Ligases
Several recent publications indicate that BH3-only proteins Bim, Puma, and Noxa can destabilize Mcl-1 [11, 13, 32] . All three proteins are important mediators of radiation-induced apoptosis [33] [34] [35] . The mechanism is thought to involve the tumor suppressor p53 that upregulates the transcription of Bim, Puma, and Noxa in response to IR-induced DNA damage [33, [35] [36] [37] [38] . However, because of a mutation, Jurkat cells do not express p53 [39] , thus an up-regulation of Bim, Puma, and Noxa was not observed in response to IR. Interestingly, Jurkat cells express the three BH3-only proteins even when not irradiated. Thus, a p53-independent mechanism has to regulate the expression of Bim, Puma, and Noxa in Jurkat cells. Although involved in IR-induced apoptosis in Previous studies repeatedly reported that phosphorylation of Mcl-1 by GSK-3β can enhance its ubiquitylation and proteasomal degradation [16] [17] [18] . However, inhibition of GSK-3β did not change Mcl-1 levels or sensitivity to IR-induced apoptosis. Moreover, IR-induced phosphorylation of Mcl-1 could not be detected (see Figure W1 ). Although phosphorylation of Mcl-1 can accelerate its degradation, it is not essential for β-TrCP-or FBW7-dependent Mcl-1 degradation [16, 18] 
Regulation of Mcl-1 Stability by Deubiquitinases
Poly-ubiquitin chains can be removed from proteins by deubiquitinases, thereby preventing proteasomal degradation and stabilizing protein levels. A recent publication by Schwickart et al. has shown that down-regulation of USP9x increased the sensitivity to apoptosis induced by the Bcl-2 inhibitor ABT-737 and delayed tumor growth in xenograft mouse model [20] . From these experiments, Schwickart et al. concluded that the Mcl-1 turnover rate and tumor growth depended on USP9x expression. Our results indicate that changed Mcl-1 turnover is also responsible for altered responsiveness to IR. The radiosensitive and radioresistant Jurkat cells, however, expressed similar amounts of USP9x. Thus, the mere USP9x expression cannot explain the difference in radiosensitivity. However, radiosensitivity clearly depended on USP9x, because down-regulation of USP9x by siRNA increased radiosensitivity in the IR-resistant Jurkat and K562 cells. In contrast to earlier observations made by Schwickart et al., USP9x knockdown did not significantly change Mcl-1 protein levels or its turnover rate in nonirradiated cells. However, Mcl-1 half-life time was greatly reduced after irradiation when USP9x was silenced in the resistant subclone. The accelerated Mcl-1 decline correlates with enhanced apoptosis induction. Obviously, USP9x is an important factor that maintains Mcl-1 stability and survival upon irradiation. IR reduced also the half-life time of Mcl-1 in resistant cells transfected with nontargeting siRNA, although only slightly and not significantly. This indicates that, apart from USP9x, other factors contribute to Mcl-1 protein stability. This assumption is also supported by Western blot analysis of IR-resistant Jurkat and K562 cells. Despite an excellent down-regulation of USP9x, IR-induced Mcl-1 decrease and caspase-3 activation did not occur to the same extent as in IR-sensitive Jurkat cells.
In the present study, we provide a link between USP9x activity, Mcl-1 stability, and radiosensitivity. USP9x becomes activated only in the resistant subclone 24 hours after IR and coincides with less ubiquitylated Mcl-1. In addition, USP9x precipitated from irradiated resistant cells was able to deubiquitylate Mcl-1 in vitro. Interestingly, IR-induced accumulation of ubiquitylated proteins in whole-cell lysates was not observed. Therefore, our results suggest a specific regulation of Mcl-1 protein levels in response to IR rather than a global shutdown of protein degradation.
So far nothing is known about the regulation of USP9x activity. USP9x becomes phosphorylated in response to IR ( Figure W1A ). Phosphorylation is often associated with changed enzymatic activity. Indeed, phosphorylation of USP9x correlated with enzymatic activity in irradiated Jurkat cells, but a direct link between phosphorylation and USP9x activation remains to be shown.
Taken together, we identified the deubiquitinase USP9x as a novel factor mediating radioresistance, which was activated in resistant cells upon irradiation and inhibited apoptosis induction by stabilizing Mcl-1 levels. 
